MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    A Neuroscientific approach for MCI Characterization using a Motor and Cognitive Dual-Task

    G. Mancioppi, F. Fiorini, M. Timpano Sportiello, E. Rovini, F. Cavallo (Pontedera, Italy)

    Objective: To investigate the relationship between cognition and motion skills, through an innovative technological tool able to quantify gait parameters, while providing for a Motor…
  • 2019 International Congress

    Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease

    A. Abundes-Corona, A. Cervantes-Arriaga, R. Zerón-Martínez, R. Solís-Vivanco, O. Cárdenas-Saenz, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To identify if the Montreal Cognitive Assessment (MoCA) is a sensible tool to differentiate cognitive impairment profiles between patients with Essential Tremor (ET) and…
  • 2019 International Congress

    Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report

    A. Costantini, M. Tan, M. Lo, L. Leyland, H. Morris, R. Weil (London, United Kingdom)

    Objective: To relate visuo-perceptual performance with cognitive and genetic measures in Parkinson’s disease. Background: Dementia is a common occurrence in Parkinson’s disease (PD), affecting up…
  • 2019 International Congress

    BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE

    Z. Kosutzka, P. Brandoburova, I. Straka, V. Veronika, P. Valkovic, M. Hajduk (Bratislava, Slovakia)

    Objective: The aim of the current study is to directly compare performance in recognition of facial and bodily emotions. Background: Patients with Parkinson´s disease (PD)  show…
  • 2019 International Congress

    Quantitative EEG measures reflect general cognitive status in Parkinson’s disease

    C. Navarro-Roa, M. Rodriguez-Violante, G. Sanchez-Dinorin, A. Cervantes-Arriaga, R. Solis-Vivanco (Mexico City, Mexico)

    Objective: To explore the utility of the quantitative electroencephalogram (EEG) as a potential biomarker of cognitive status in patients with Parkinson's disease (PD). Background: While…
  • 2019 International Congress

    Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil

    N. Sousa, A. Neri, I. Brandi, S. Brucki (Salvador, Brazil)

    Objective: To determine the impact of cognitive training (CT) on cognitive and quality of life measures in patients with Parkinson's Disease (PD). Background: PD is…
  • 2019 International Congress

    Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

    B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)

    Objective: Investigate cognitive mechanisms contributing to olfactory dysfunction in Parkinson’s disease. Background: Accurate early diagnosis of Parkinson’s disease is hampered by its long prodromal period…
  • 2019 International Congress

    Primary disruption of the subsystems of the default mode network in drug-naïve Parkinson’s disease with mild cognitive impairments: a resting-state functional connectivity MRI study

    YB. Hou, QQ. Wei, RW. Ou, J. Yang, W. Song, QY. Gong, HF. Shang (Chengdu, China)

    Objective: To study changes in subsystems in drug-naïve Parkinson’s disease with mild cognitive impairments using resting-state functional connectivity MRI. Background: Mild cognitive impairment (MCI) is common…
  • 2019 International Congress

    Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)

    A. Mullin, R. Fuller, G. Stebbins, J. Stout, A. Robbins, P. Feigenbaum, M. Roche, E. Gantman, C. Sampaio, M. Brumfield (Tucson, AZ, USA)

    Objective: To align with regulators on the utility and development strategy of novel clinical outcome assessments for use in Huntington’s disease (HD) clinical trials. Background:…
  • 2019 International Congress

    Efficacy of Motor Imagery Questionnaire-RS as a Diagnostic Tool in Rehabilitation of Movement Disorders

    D. Kaur, N. Bhardwaj, S. Kumari, S. Kumari, A. Gupta, G. Kumar (Patna, India)

    Objective: The present study attempts to establish the normative reference value for motor imagery and compare it with patients with movement disorders. Background: Motor imagery,…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley